All Stories

  1. Two-year progression of different phenotypes.
  2. Ocular and Systemic Risk Markers for Development of Macular Edema and Proliferative Retinopathy in Type 2 Diabetes: A 5-Year Longitudinal Study
  3. Multimodal Imaging of the Initial Stages of Diabetic Retinopathy: Different Disease Pathways in Different Patients
  4. Real life study of the diabetic macular edema treatment with ranibizumab
  5. Microaneurysm turnover in the macula is a biomarker for development of clinically significant macular edema in type 2 diabetes